Iterative Health Funding: $195M Raised, Series C (2025)
Iterative Health is based in New York, NY. It has raised $195M in total funding. Latest round: Series C.
Iterative Health funding overview
Iterative Health is based in New York, NY. Iterative Health has raised $195M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2025. The round record for Iterative Health runs through 2025; nothing later has been disclosed. Investors on record include Johnson & Johnson, Eli Lilly, Insight Partners, Breyer Capital, Alumni Ventures, Dawn Capital and 1 others. 7 distinct backers are named across the disclosed rounds.
Iterative Health at a glance
Total raised
$195M
Latest round
Series C
Latest round date
January 2025
Headquarters
New York, NY
Notable investors
Johnson & Johnson, Eli Lilly, Insight Partners, Breyer Capital, Alumni Ventures, Dawn Capital, Obvious Ventures
Frequently asked about Iterative Health funding
How much has Iterative Health raised?
Iterative Health has raised $195M in total disclosed funding across the rounds on record.
Who has invested in Iterative Health?
Johnson & Johnson, Eli Lilly, Insight Partners, Breyer Capital, Alumni Ventures, Dawn Capital are named among the investors backing Iterative Health.
What was the latest Iterative Health funding round?
The most recent disclosed round is a Series C, announced in January 2025.
Where is Iterative Health based?
Iterative Health is based in New York, NY.
When did Iterative Health last raise?
The last disclosed Iterative Health round closed in January 2025 at Series C.
Round data for Iterative Health is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in New York and backer lists below.
